A truncated peptide Spgillcin177-189 derived from mud crab Scylla paramamosain exerting multiple antibacterial

Xiaofei Wang1, Xiao Hong1, Fangyi Chen1,2,3

  • 1State Key Laboratory of Marine Environmental Science, College of Ocean and Earth Sciences, Xiamen University, Xiamen, China.

Insights

A novel antimicrobial peptide, Spgillcin, derived from the mud crab Scylla paramamosain, demonstrates potent broad-spectrum antibacterial activity against multidrug-resistant strains. This peptide shows promise as a safe and effective alternative to conventional antibiotics in aquaculture and medicine.

Area of Science:

  • Marine biology
  • Biochemistry
  • Immunology

Background:

  • Antimicrobial peptides (AMPs) are crucial in innate immunity and represent promising alternatives to antibiotics.
  • Pathogenic bacteria, including multidrug-resistant (MDR) strains, pose a significant threat to human health and aquaculture.
  • The mud crab, Scylla paramamosain, is a valuable aquaculture species with potential for novel antimicrobial discoveries.

Purpose of the Study:

  • To identify and characterize a novel antimicrobial peptide from Scylla paramamosain.
  • To evaluate the antibacterial activity, mechanism of action, and safety of the peptide.
  • To assess the potential of the peptide as a substitute for antibiotics.

Main Methods:

  • Gene cloning and sequencing to identify the Spgillcin gene.
  • Quantitative real-time PCR to analyze Spgillcin expression in vivo.
  • Synthesis and in vitro antibacterial assays of the truncated peptide Spgillcin177-189.
  • Cytotoxicity assays on mammalian cells.
  • Mechanistic studies involving membrane integrity and reactive oxygen species.
  • Antibiotic resistance development assays and anti-biofilm activity tests.

Main Results:

  • The Spgillcin gene was identified, encoding a 216-amino acid peptide predominantly expressed in crab gills and upregulated upon Staphylococcus aureus challenge.
  • The synthesized peptide Spgillcin177-189 exhibited potent, broad-spectrum activity against various bacterial strains, including MDR isolates, with MICs ranging from 1.5 to 48 μM.
  • Spgillcin177-189 demonstrated rapid bactericidal kinetics, no cytotoxicity to mammalian cells, stability under various conditions, and efficacy against biofilms.
  • No resistance developed against Spgillcin177-189 after prolonged exposure to resistant bacterial strains.
  • Mechanisms involved cell membrane disruption, increased permeability, and reactive oxygen species accumulation.

Conclusions:

  • Spgillcin is a novel antimicrobial peptide from Scylla paramamosain with significant potential.
  • The truncated peptide Spgillcin177-189 displays potent antibacterial, anti-biofilm, and safety profiles.
  • Spgillcin177-189 is a promising candidate for developing new antimicrobial agents for aquaculture and medical applications.